We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MES
4951
DELISTED
VANECK VECTORS GULF STATES INDEX ETF
MES
-100
Closed -$2K
RUSL
4952
DELISTED
Direxion Daily Russia Bull 2X Shares
RUSL
-80
Closed -$3K
RVLT
4953
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
-1,399
Closed -$9K
IO
4954
DELISTED
ION Geophysical Corporation
IO
-1,550
Closed -$11K
FCE.B
4955
DELISTED
Forest City Realty Trust, Inc.
FCE.B
-821
Closed -$19K
NYNY
4956
DELISTED
Empire Resorts, Inc.
NYNY
-163
Closed -$3K
RGRO
4957
DELISTED
Oppenheimer Global Growth Revenue ETF
RGRO
-125
Closed -$6K
ATV
4958
DELISTED
Acorn International
ATV
-740
Closed -$8K
CIZ
4959
DELISTED
VictoryShares Developed Enhanced Volatility Wtd ETF
CIZ
-301
Closed -$9K
CID
4960
DELISTED
VictoryShares International High Div Volatility Wtd ETF
CID
-400
Closed -$13K
NLSN
4961
DELISTED
Nielsen Holdings plc
NLSN
-2,552
Closed -$137K
AOI
4962
DELISTED
Alliance One International
AOI
-813
Closed -$16K
WPZ
4963
DELISTED
Williams Partners L.P.
WPZ
-5,326
Closed -$198K
IID
4964
DELISTED
VOYA INTERNATIONAL HIGH DIVIDEND EQUITY INCOME FUND
IID
-199
Closed -$1K
DCTH
4965
DELISTED
Delcath Systems Inc
DCTH
-100
Closed
VRTB
4966
DELISTED
Vestin Realty Mortgage II, Inc.
VRTB
-39
Closed
USLV
4967
DELISTED
VelocitySharesTM 3x Long Silver ETN linked to the S&P GSCI Silver Index ER
USLV
-10
Closed -$2K
MHE
4968
DELISTED
BlackRock Massachusetts Tax-Exempt Trust
MHE
$0 ﹤0.01%
35
-402
-92% -$5.42K
CELGZ
4969
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
-800
Closed -$1K
GALTW
4970
DELISTED
Galectin Therapeutics Inc. - Warrants
GALTW
$0 ﹤0.01%
133
PHIIK
4971
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
-99
Closed -$2K
USATP
4972
DELISTED
USA Technologies, Inc. - Preferred Stock
USATP
-500
Closed -$10K
ZIONW
4973
DELISTED
Zions Bancorporation N.A. Warrants
ZIONW
-800
Closed -$3K
WAFDW
4974
DELISTED
Washington Federal, Inc.
WAFDW
-400
Closed -$4K
FBC
4975
DELISTED
Flagstar Bancorp, Inc. New
FBC
-400
Closed -$11K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.